(3-(Pyridin-3-yl)-1H-1,2,4-triazol-5-yl)methanamine dihydrochloride

Catalog No. :
ACYVWZ951
CAS No. :
1258650-65-5
Molecular Formula :
C8H11Cl2N5
Molecular Weight :
248.12

IUPAC Name:(3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl)methanamine dihydrochloride

(3-(Pyridin-3-yl)-1H-1,2,4-triazol-5-yl)methanamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$299.00Login to see priceInquiryInquiry
100mg98%$437.00Login to see priceInquiryInquiry
250mg98%$615.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3-(Pyridin-3-yl)-1H-1,2,4-triazol-5-yl)methanamine dihydrochloride
IUPAC Name(3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl)methanamine dihydrochloride
MDL No.MFCD17480399
Molecular FormulaC8H11Cl2N5
Molecular Weight248.12
SMILESNCC1=NC(C2=CC=CN=C2)=NN1.[H]Cl.[H]Cl
InChI KeyGNEAQNCWZGEBCE-UHFFFAOYSA-N
Synonym[3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl]methanamine dihydrochloride;3-(Pyridin-3-yl)-1H-1,2,4-triazol-5-ylmethanamine dihydrochloride(3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl)methanamine 2HCl;(5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)methanamine hydrochloride
CAS No.1258650-65-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYVWZ951 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYVWZ951 route product structure diagram
    ACYVWZ9511258650-65-5
Inquiry

2. ACYVWZ951 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYVWZ951 route product structure diagram
    ACYVWZ9511258650-65-5
Inquiry

Comments (0)